H. Kirk Hammond
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$3.4MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $3.4M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 31, 2023 | NIH | STTR Phase II Urocortin-2 Gene Transfer for Type 1 Diabetes and Associated LV Dysfunction | $793K | Renova Therapeutics, Inc. |
| Jun 17, 2022 | NIH | STTR Phase II Urocortin-2 Gene Transfer for Type 1 Diabetes and Associated LV Dysfunction | $806K | Renova Therapeutics, Inc. |
| Sep 19, 2019 | NIH | STTR Phase II Urocortin-2 Gene Transfer for Type 1 Diabetes and Associated LV Dysfunction | $242K | Renova Therapeutics, Inc. |
| Nov 25, 2016 | NIH | STTR Phase II Urocortin-2 Gene Transfer for CHF: a Paracrine Approach Using Intravenous AAV8 | $803K | Renova Therapeutics, Inc. |
| Nov 10, 2015 | NIH | STTR Phase II Urocortin-2 Gene Transfer for CHF: a Paracrine Approach Using Intravenous AAV8 | $803K | Renova Therapeutics, Inc. |
Peer ranks
Federal funding#501
Awards as PI#417
Patents#273
Companies
- Renova Therapeutics, Inc.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.